HMG-CoA Reductase Inhibitors (Statin) Prevents Retinal Neovascularization in a Model of Oxygen-Induced Retinopathy | Zendy

Manuela Bartoli | Zendy; Mohamed AlShabrawey | Zendy; M. Labazi | Zendy; M. Ali Behzadian | Zendy; Mohamed Istanboli | Zendy; Azza B. ElRemessy | Zendy; Robert W. Caldwell | Zendy; Dennis M. Marcus | Zendy; Ruth B. Caldwell | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

HMG-CoA Reductase Inhibitors (Statin) Prevents Retinal Neovascularization in a Model of Oxygen-Induced Retinopathy

Author(s) -

Manuela Bartoli,

Mohamed AlShabrawey,

M. Labazi,

M. Ali Behzadian,

Mohamed Istanboli,

Azza B. ElRemessy,

Robert W. Caldwell,

Dennis M. Marcus,

Ruth B. Caldwell

Publication year - 2009

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.08-2158

Subject(s) - neovascularization , statin , retinal , pharmacology , fluvastatin , medicine , lipid peroxidation , ischemia , oxidative stress , angiogenesis , ophthalmology , simvastatin

Retinal neovascularization (RNV) is a primary cause of blindness and involves the dysfunction of retinal capillaries. Recent studies have emphasized the beneficial effects of inhibitors of HMG-CoA reductase (statins) in preventing vascular dysfunction. In the present study, the authors characterized the therapeutic effects of statins on RNV.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research